Key Points
- Insider purchase: On December 15, insider Julian Baines bought 85,000 shares of EKF at an average price of GBX 23, a transaction valued at £19,550.
- Stock performance & valuation: EKF opened at GBX 24.90, trading below its 50‑day (GBX 25.78) and 200‑day (GBX 27.29) moving averages, with a 1‑year range of GBX 18.40–32, a market cap of £108.41m and a P/E of 18.44.
- Fundamentals & business profile: EKF reported quarterly EPS of GBX 0.43 with a net margin of 9.37% and ROE of 7.03%, analysts forecast ~2.30 EPS for the year, and the AIM‑listed company focuses on point‑of‑care hematology/diabetes analyzers and life‑sciences manufacturing across five sites and 120+ countries.
EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) insider Julian Baines acquired 85,000 shares of the firm's stock in a transaction that occurred on Monday, December 15th. The shares were bought at an average price of GBX 23 per share, with a total value of £19,550.
EKF Diagnostics Price Performance
EKF opened at GBX 24.90 on Wednesday. The business's 50-day moving average is GBX 25.78 and its two-hundred day moving average is GBX 27.29. EKF Diagnostics Holdings plc has a 1 year low of GBX 18.40 and a 1 year high of GBX 32. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The firm has a market capitalization of £108.41 million, a PE ratio of 18.44 and a beta of 0.57.
EKF Diagnostics (LON:EKF - Get Free Report) last released its quarterly earnings results on Tuesday, September 16th. The company reported GBX 0.43 EPS for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. Research analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.
EKF Diagnostics Company Profile
(
Get Free Report)
EKF is an AIM-listed global diagnostics business focussed on:
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
